Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Transgene presents phase II data for cancer vaccine

Dec. 23, 1999

StressGen's new treatment for cervical dysplasia successfully completes phase I study

Dec. 14, 1999

Cell Genesys receives payment from Japan Tobacco for cancer vaccine milestone

Dec. 14, 1999

KRN-7000-stimulated human cells effective in vitro against melanoma cell lines

Dec. 13, 1999

ImmunoGen's lead tumor-activated prodrug enters the clinic

Dec. 13, 1999

LifeTime receives FDA clearance to begin phase I/II trials of anticancer drug

Dec. 10, 1999

Avax Technologies and Neptunus execute joint venture agreement

Dec. 3, 1999

Schering in-licenses human antibody for gastric cancer

Dec. 2, 1999

Biomira enters collaborative agreement, licenses two patents for cancer vaccine

Nov. 29, 1999

Preliminary survival data from single Maxamine site submitted to ASCO

Nov. 24, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...